Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
Claims that semaglutide microdosing works to maintain weight loss and manage blood sugar are mainly anecdotal and not backed by scientific research.
Clinical Pharmacology April 9th 2025
Verywell Health
A Lilly spokesperson told Verywell that about 10% of people who start taking Zepbound for the first time enroll in the self-pay program. This includes people who previously used compounded tirzepatide.
Clinical Pharmacology April 8th 2025
GoodRx for Healthcare Professionals
Some medications can be dangerous to stop abruptly. Not only could your medical condition get worse, but you could also experience problematic side effects or withdrawal symptoms.
All Specialties April 1st 2025
MedCentral
Unacceptable levels of N-nitroso atomoxetine, a potential carcinogen, were found in multiple atomoxetine batches, according to the FDA.
Clinical Pharmacology April 1st 2025
“It’s absolutely not nature’s Ozempic and does not work like Ozempic, which is a GLP-1 inhibitor. Manufacturers of these supplements are just kind of creating a hype…”
Clinical Pharmacology March 31st 2025
Cleveland Clinic Journal of Medicine (CCJM)
Nonantimicrobial sulfonamides lack an arylamine group at the N4 position, so they do not cross-react with antimicrobial sulfonamides.
Allergy & Immunology March 31st 2025